SRS Capital Advisors »

Bicycle Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $205 29 7.07

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Fcpm Iii Services B.v.
Westfield Capital Management Company
Armistice Capital
Siren
Acadian Asset Management
Long Focus Capital Management
Candriam Luxembourg S.C.A.
Principal Financial Group
Millennium Management
Schroder Investment Management Group
Bnp Paribas Investment Partners
Renaissance Technologies
Silvercrest Asset Management Group
Birchview Capital

View all funds holding Bicycle Therapeutics